Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
980 studies found for:    Open Studies | "Colorectal Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Implementation of a New Strategy to Identify HNPCC Patients
Conditions: Colorectal Neoplasms;   Hereditary Nonpolyposis Colorectal Cancer
Interventions: Behavioral: Education for professionals;   Behavioral: Distribution of educational materials;   Behavioral: Feedback for professionals;   Behavioral: Reminders for professionals
22 Recruiting Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: ABI-007
23 Unknown  Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasm
Intervention: Drug: recombinant human endostatin (Endostat)
24 Recruiting COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy
Condition: Colorectal Neoplasms
Interventions: Drug: Regorafenib (Stivarga, BAY73-4506);   Drug: Placebo
25 Recruiting Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasms;   Metastatic Disease
Intervention: Drug: Regorafenib
26 Recruiting Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
Condition: Colorectal Neoplasms
Interventions: Device: SIR-Spheres;   Drug: Regorafenib
27 Recruiting Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab
Conditions: Colorectal Neoplasms;   Metastatic Disease
Intervention: Drug: Regorafenib
28 Not yet recruiting Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Colorectal Cancer
Interventions: Drug: 5-FU;   Drug: LV;   Drug: ziv-aflibercept;   Drug: mFOLFOX6
29 Recruiting Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network
Condition: Colorectal Neoplasm
Intervention: Device: cap-assisted chromoendoscopy
30 Unknown  Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
Conditions: Colorectal Cancer;   Hereditary Nonpolyposis Colorectal Cancer;   Precancerous Condition
Interventions: Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors;   Procedure: study of high risk factors
31 Recruiting Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: Capecitabine
32 Recruiting Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: folic acid;   Drug: folic acid  calcium  vitamin D3;   Drug: calcium
33 Recruiting A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: RRx-001;   Drug: Regorafenib
34 Recruiting Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy
Condition: Colorectal Neoplasm
Intervention: Drug: Regorafenib (Stivarga, BAY 73-4506)
35 Recruiting Nintedanib (BIBF 1120) vs Placebo in Refractory Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: Nindetanib (BIBF 1120);   Drug: Placebo;   Drug: BSC
36 Recruiting New Adjuvant Chemotherapy of Non Resectable Liver Metastasis of Colorectal Cancer Without Bleeding, Obstruction
Conditions: Colorectal Neoplasms;   Neoplasm Metastasis;   Liver Neoplasms;   Chemotherapy; Maternal, Affecting Fetus
Intervention: Drug: chemotherapy ± targeted therapy
37 Available Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
Condition: Colorectal Neoplasms
Intervention: Drug: Regorafenib (BAY73-4506)
38 Not yet recruiting Study of Andrographolides With or Without Capecitabine to Treat Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: Andrographolides;   Drug: Capecitabine
39 Recruiting Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: Bevacizumab;   Drug: Capecitabine;   Drug: Levocetirizine
40 Not yet recruiting Assessing The Effectiveness of a Preoperative High Intensity Interval Training Programme In Older Colorectal Cancer Patients
Conditions: Preoperative Care;   Colorectal Neoplasms;   Aged;   Exercise
Intervention: Behavioral: HIT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years